Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD).

The outcome of 114 patients with tumour-induced hypercalcaemia (TIH) treated between January 1992 and June 1993 with intravenous pamidronate (APD) was retrospectively analysed. The median overall survival was 55 days (range 3 days to > 21 months): 86 days if systemic anti-cancer therapy was avail...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, P. J., A'Hern, R. P., Hardy, J. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034143/
https://www.ncbi.nlm.nih.gov/pubmed/7599053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034143/
https://www.ncbi.nlm.nih.gov/pubmed/7599053

Ejemplares similares